News | May 08, 2026
Sanofi India partners with NHM MP to expand NCD, rare disease services
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
The initiative pairs consumer engagement with a public health message about prevention and early detection
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Subscribe To Our Newsletter & Stay Updated
